SR7826 is a potent and selective LIMK inhibitor. References: Yu Q, Gratzke C, Wang Y, Herlemann A, Sterr CM, Rutz B, Ciotkowska A, Wang X, Strittmatter F, Stief CG, Hennenberg M. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3. Br J Pharmacol. 2018 Jun;175(11):2077-2096. doi: 10.1111/bph.14201. Epub 2018 Apr 29. PubMed PMID: 29574791; PubMed Central PMCID: PMC5978953.
纯度:≥98%
CAS:1219728-20-7